Related Experiment Video
Updated: Jun 8, 2026
04:47
Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
Published on: October 27, 2023
Genomics of ankylosing spondylitis
Gethin P Thomas1, Matthew A Brown
1University of Queensland Diamantina Institute, Woolloongabba, Queensland, 4102, Australia. gethin.thomas@uq.edu.au
Discovery Medicine
|September 30, 2010
Summary
Ankylosing spondylitis (AS) is a debilitating spinal arthritis characterized by bone overgrowth. Gene expression profiling shows promise for early AS diagnosis, but larger, collaborative studies are needed.
Area of Science:
- Rheumatology
- Genetics
- Molecular Biology
Background:
- Ankylosing spondylitis (AS) is a prevalent and disabling spondyloarthropathy targeting the spine and pelvis.
- Unlike other arthritides, AS involves uncontrolled bone formation, leading to joint fusion and disability.
- AS affects an estimated 2.4 million individuals in the U.S., twice the number with rheumatoid arthritis.
Purpose of the Study:
- To elucidate the underlying mechanisms and pathways driving ankylosing spondylitis pathogenesis.
- To investigate the utility of gene expression profiling for understanding cellular activity in AS.
- To explore the potential of expression profiling for early diagnosis of AS.
Main Methods:
- Utilized genome-wide association study (GWAS) approaches to identify candidate genes associated with AS.
- Conducted gene expression profiling studies on circulating cells and tissues from affected joints in AS patients.
- Analyzed data from low-power and more recent, higher-powered expression profiling studies.
Main Results:
- GWAS identified several candidate genes linked to AS, but do not reveal real-time gene/cell activity changes.
- Initial expression profiling studies in AS yielded disappointing results with little consensus due to low statistical power.
- Recent, better-powered studies have identified diagnostic expression profiles, suggesting a role for expression profiling in early AS detection.
Conclusions:
- Gene expression profiling offers a snapshot of cellular activity and potential diagnostic markers for AS.
- The pathogenesis of AS remains poorly understood, highlighting the need for advanced genetic and expression analysis.
- Future research requires collaborative efforts with larger sample sizes, targeting specific disease stages and sites for robust findings.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...